XFOR: X4 Pharmaceuticals Inc. Kompaniya qiymatining sof foydaga nisbati
X4 Pharmaceuticals (XFOR) noyob immun buzilishlarini davolashga ixtisoslashgan bo'lib, dori vositalarini kashf etishni tezlashtirish uchun AI va avtomatlashtirilgan skriningdan foydalanadi. Ushbu PE grafigi -4.20 qiymatini aks ettiradi. Biznes ishlab chiqarish xarajatlari past bo'lgan mualliflik formulalariga tayanadi, zavodlar va robotlashtirilgan omborlar bilan optimallashtirilgan muvofiqlashtirish esa dori vositalarining uzluksiz ishlab chiqarilishi va yetkazib berilishini ta'minlaydi.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwbxec28.yq-7cu2wow&start=20220704&end=20261111&filename=GURU_Markets_-_XFOR_-_X4-Pharmaceuticals_-_PE-Multiple "XFOR: X4 Pharmaceuticals Biznesning o‘zini qoplash muddati 04.07.2022 - 11.11.2026 | 👁️GURU.Markets👁️")
X4 Pharma (XFOR) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati X4 Pharmaceuticals|XFOR - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati X4 Pharmaceuticals, Inc|XFOR - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati X4 Pharmaceuticals, Inc.|XFOR - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz X4 Pharmaceuticals|Shoshilinch likvidlik koeffitsiyenti x4pharma.com
- foyda va bozor multiplikatorlari tafsilotlari:
XFOR - Kompaniya foydasi|Kelajakdagi foyda X4 Pharmaceuticals|XFOR - Kompaniya qiymatining sof foydaga nisbati|Kelajakdagi narxning foydaga nisbati X4 Pharmaceuticals Inc.|XFOR - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|EV/EBITDA multiplikatori X4 Pharmaceuticals, Inc.|XFOR - Foizlar, soliqlar va amortizatsiya chegirilmasdan oldingi daromad|Bir aksiya uchun sof foyda (EPS TTM) X4 Pharmaceuticals|XFOR - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi x4pharma.com|XFOR - Joriy yilda bir aksiya uchun foyda ortishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi X4 Pharmaceuticals
Kompaniyaning har tomonlama tahlili:x4pharma.com XFOR
Emitentning qiymatini ob'ektiv baholash uchun menejer foyda birligi narxini aniqlash maqsadida bozor kapitalizatsiyasini sof foyda bilan bog'lashi kerak. X4 Pharmaceuticals (XFOR) kompaniyasining yillik P/E ko'rsatkichini tahlil qilish orqali investor aktivlarning haddan tashqari qimmat baholanganligini aniqlashi mumkin, ayniqsa X4 Pharmaceuticals (XFOR) aksiyalari narxining o'sishi Xolremdi tijoratlashtirilishidan olingan haqiqiy moliyaviy foyda va dori vositasining sug'urta qamrovining kengayishidan oshib ketgan hollarda.
Muhim raqobatchilar
P/E multiplikatori argenx.com|Narx-foyda koeffitsiyenti BNTX (BioNTech)|ABVX (ABIVAX) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (ADMA Bio)|Biznesning o‘zini qoplash muddati Protagonist Corp (PTGX)|IMVT - Narxning foydaga nisbati|kiniksa.com (KNSA) - Narx-foyda koeffitsiyenti|Grifols (GRFS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Adaptive Biotech|Narx-foyda koeffitsiyenti CLDX|P/E multiplikatori Aurinia Corp|Narxning foydaga nisbati BioCryst (BCRX)|veratx.com - Narx-foyda multiplikatori|P/E multiplikatori DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV (PHVS) - Kapitalizatsiyaning foydaga nisbati|ABCL: Narx-foyda koeffitsiyenti|TRML (Tourmaline) - Narx-foyda multiplikatori|Narx-foyda multiplikatori Precigen, Inc.|Narx-foyda koeffitsiyenti pharming.com|NKTR - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati UPB|ZBIO - Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori Immunome Bio (IMNM)|Kompaniya qiymatining sof foydaga nisbati Gossamer Bio, Inc.|P/E multiplikatori kalvista.com KALV|Septerna - P/E multiplikatori|PVLA: Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati Savara Corp SVRA|RIGL (Rigel Corp) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti ANAB|P/E multiplikatori astriatx.com|P/E multiplikatori ENGN|P/E multiplikatori RAPT Therapeutics Inc. (RAPT)|Aerovate Therapeutics - Narx-foyda koeffitsiyenti|P/E multiplikatori Aclaris Therapeutics, Inc ACRS|KYTX (Kyverna Therapeutics) - Kapitalizatsiyaning foydaga nisbati|tizianalifesciences.com (TLSA) - Narx-foyda koeffitsiyenti|CABA: P/E multiplikatori|Narx-foyda koeffitsiyenti Ventyx Biosciences Inc.|Theratechnologies Inc (THTX) - Bozor narxining sof foydaga nisbati|P/E multiplikatori Avalo Therapeutics Inc|ELDN (Eledon Pharmaceuticals) - Biznesning o‘zini qoplash muddati|P/E multiplikatori agenusbio.com (AGEN)|Climb Bio - Narx-foyda koeffitsiyenti|P/E multiplikatori Zura Bio Ltd ZURA|aTyr - P/E multiplikatori|ADAG: Narxning foydaga nisbati|ikenaoncology.com (IMA) - Narxning foydaga nisbati|STTK (Shattuck Labs) - Narxning foydaga nisbati|EQ: Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti Connect Pharma (CNTB)|Narx-foyda multiplikatori Immunic, Inc. IMUX|P/E multiplikatori atarabio.com (ATRA)|InflaRx (IFRX) - Kapitalizatsiyaning sof foydaga nisbati|Adicet Bio Inc. - Narxning foydaga nisbati|CELU (Celularity Corp) - Kapitalizatsiyaning foydaga nisbati|INMB: Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati Barinthus Bio BRNS|KZR (Kezar Life Sciences Inc) - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati SAB Biotherapeutics SABS|P/E multiplikatori akaritx.com|Enlivex Therapeutics (ENLV) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori q32bio.com (QTTB)|P/E multiplikatori GOVX (GeoVax Labs Inc)|Edesa Biotech Corp - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati iBio, Inc. (IBIO)|CARM: Narxning foydaga nisbati|XTLB (XTL Biopharmaceuticals Ltd.) - Narx-foyda koeffitsiyenti|Bolt Biotherapeutics, Inc. (BOLT) - P/E multiplikatori|HCWB (HCW Biologics, Inc.) - P/E multiplikatori|Narx-foyda koeffitsiyenti Aptevo (APVO)|AIM ImmunoTech Inc. (AIM) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori aditxt.com (ADTX)|Biznesning o‘zini qoplash muddati GRI|XORTX Therapeutics Inc - Narxning foydaga nisbati|HIND: Narx-foyda koeffitsiyenti|REVB: Narxning foydaga nisbati|INDP (Indaptus Therapeutics) - Narx-foyda koeffitsiyenti|Narx-foyda koeffitsiyenti scinai.com|CALI (CalciMedica Inc) - P/E multiplikatori|Narxning foydaga nisbati AFMD|Narx-foyda multiplikatori Allakos Inc. ALLK|P/E multiplikatori hookipapharma.com (HOOK)|IGMS: Kapitalizatsiyaning foydaga nisbati|ITOS - Narx-foyda koeffitsiyenti|Ocean Biomedical (OCEA) - Narx-foyda multiplikatori|TCBP (TC BioPharm (Holdings) Plc) - Narx-foyda multiplikatori|THRD (Third Harmonic Bio, Inc) - Narx-foyda koeffitsiyenti
